{"id":47975,"date":"2022-09-05T17:01:51","date_gmt":"2022-09-05T15:01:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/"},"modified":"2022-09-05T17:01:51","modified_gmt":"2022-09-05T15:01:51","slug":"united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/","title":{"rendered":"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644468\/us-benign-prostatic-hyperplasia-market-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=4qvrkw&amp;utm_campaign=1745533+-+United+States+Benign+Prostatic+Hyperplasia+Markets+and+Competitive+Landscape+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;US Benign Prostatic Hyperplasia Market and Competitive Landscape &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/21\/logo.jpg\"><\/a><\/p>\n<p>\nUS Benign Prostatic Hyperplasia Market and Competitive Landscape report provides comprehensive insights into Benign Prostatic Hyperplasia pipeline products, Benign Prostatic Hyperplasia epidemiology, Benign Prostatic Hyperplasia market valuations and forecast, Benign Prostatic Hyperplasia drugs sales and competitive landscape in the US.\n<\/p>\n<p>\nThe research is classified into seven sections &#8211; Benign Prostatic Hyperplasia treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.\n<\/p>\n<p>\n<strong>Research Scope:<\/strong>\n<\/p>\n<ul>\n<li>\nBenign Prostatic Hyperplasia pipeline: Find out the products in clinical trials for the treatment of Benign Prostatic Hyperplasia by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products\n<\/li>\n<li>\nBenign Prostatic Hyperplasia epidemiology: Find out the number of patients diagnosed (prevalence) with Benign Prostatic Hyperplasia in the US\n<\/li>\n<li>\nBenign Prostatic Hyperplasia drugs: Identify key products marketed and prescribed for Benign Prostatic Hyperplasia in the US, including trade name, molecule name, and company\n<\/li>\n<li>\nBenign Prostatic Hyperplasia drugs sales: Find out the sales revenues of Benign Prostatic Hyperplasia drugs in the US\n<\/li>\n<li>\nBenign Prostatic Hyperplasia market valuations: Find out the market size for Benign Prostatic Hyperplasia drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027\n<\/li>\n<li>\nBenign Prostatic Hyperplasia drugs market share: Find out the market shares for key Benign Prostatic Hyperplasia drugs in the US\n<\/li>\n<\/ul>\n<p>\n<strong>Benefits of this Research<\/strong>\n<\/p>\n<ul>\n<li>\nSupport monitoring and reporting national Benign Prostatic Hyperplasia market analysis and sales trends\n<\/li>\n<li>\nTrack competitor drugs sales and market share in the US Benign Prostatic Hyperplasia market\n<\/li>\n<li>\nTrack competitive developments in Benign Prostatic Hyperplasia market and present key issues and learnings\n<\/li>\n<li>\nSynthesize insights for Benign Prostatic Hyperplasia market and products to drive business performance\n<\/li>\n<li>\nAnswer key business questions about the Benign Prostatic Hyperplasia market\n<\/li>\n<li>\nEvaluate commercial market opportunity assessment, positioning, and segmentation for Benign Prostatic Hyperplasia products\n<\/li>\n<li>\nSupports decision making in R&amp;D to long term marketing strategies\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n1) Benign Prostatic Hyperplasia Treatments\n<\/p>\n<p>\n2) Benign Prostatic Hyperplasia Pipeline\n<\/p>\n<p>\n3) US Benign Prostatic Hyperplasia Epidemiology\n<\/p>\n<p>\n4) Marketed Drugs for Benign Prostatic Hyperplasia in US\n<\/p>\n<p>\n5) US Benign Prostatic Hyperplasia Market Size and Forecast\n<\/p>\n<p>\n6) US Benign Prostatic Hyperplasia Products Sales and Forecast\n<\/p>\n<p>\n7) US Benign Prostatic Hyperplasia Market Competitive Landscape\n<\/p>\n<p>\n8) Methodology\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644468\/us-benign-prostatic-hyperplasia-market-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=4qvrkw&amp;utm_campaign=1745533+-+United+States+Benign+Prostatic+Hyperplasia+Markets+and+Competitive+Landscape+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/5dixdz<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;p&#x72;&#101;s&#x73;&#64;&#x72;&#x65;s&#x65;&#97;r&#x63;&#104;a&#x6e;&#100;&#x6d;&#x61;&#114;&#x6b;&#x65;t&#x73;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;&#97;&#110;&#100;&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#46;com<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Benign Prostatic Hyperplasia Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. US Benign Prostatic Hyperplasia Market and Competitive Landscape report provides comprehensive insights into Benign Prostatic Hyperplasia pipeline products, Benign Prostatic Hyperplasia epidemiology, Benign Prostatic Hyperplasia market valuations and forecast, Benign Prostatic Hyperplasia drugs sales and competitive &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47975","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Benign Prostatic Hyperplasia Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. US Benign Prostatic Hyperplasia Market and Competitive Landscape report provides comprehensive insights into Benign Prostatic Hyperplasia pipeline products, Benign Prostatic Hyperplasia epidemiology, Benign Prostatic Hyperplasia market valuations and forecast, Benign Prostatic Hyperplasia drugs sales and competitive ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-05T15:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-05T15:01:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/\"},\"wordCount\":444,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005345\\\/en\\\/1561422\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/\",\"name\":\"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005345\\\/en\\\/1561422\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-05T15:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005345\\\/en\\\/1561422\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005345\\\/en\\\/1561422\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Benign Prostatic Hyperplasia Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. US Benign Prostatic Hyperplasia Market and Competitive Landscape report provides comprehensive insights into Benign Prostatic Hyperplasia pipeline products, Benign Prostatic Hyperplasia epidemiology, Benign Prostatic Hyperplasia market valuations and forecast, Benign Prostatic Hyperplasia drugs sales and competitive ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-05T15:01:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-09-05T15:01:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/"},"wordCount":444,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/","name":"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/21\/logo.jpg","datePublished":"2022-09-05T15:01:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220905005345\/en\/1561422\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/united-states-benign-prostatic-hyperplasia-markets-and-competitive-landscape-report-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"United States Benign Prostatic Hyperplasia Markets and Competitive Landscape Report 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47975"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47975\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}